Work

MDS-539 Understanding the Real-World Clinical Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)01195-3

Authors: Jesse Fishman, Carly Rich, Koo Wilson, Jennifer Mellor-Bowman, Lucy Earl, Yasmin Taylor, Alice Simons, Joe Conyers

Institutions: Apellis Pharmaceuticals (United States), Swedish Orphan Biovitrum (Sweden), Adelphi Group (United Kingdom)

Language: English

Topic: Complement system in diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4386282191

Cites:

Cited by:

Related to: 10